CASI Pharmaceuticals, Inc.
Related Filers (3)
Other (21)
6-K
Monday, 2/12/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/30/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/15/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 11/8/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
CORRESP
Friday, 8/25/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Friday, 8/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 8/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 5/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 4/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Wednesday, 4/26/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Wednesday, 4/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
8-A12B
Monday, 3/27/2023
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
6-K
Tuesday, 3/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Monday, 2/13/2023
Notice of Effectiveness
F-4/A
Thursday, 2/9/2023
Registration statement for securities issued by foreign private issuers in certain business combination transactions
CORRESP
Thursday, 2/9/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-4
Tuesday, 1/31/2023
Registration statement for securities issued by foreign private issuers in certain business combination transactions
Ownership (5)
SC 13G/A
Friday, 1/26/2024
Huang James: Major Shareholders
SC 13G/A
Thursday, 11/9/2023
Huang James: Major Shareholders
SC 13G/A
Friday, 6/23/2023
Huang James: Major Shareholders
SC 13D/A
Tuesday, 4/18/2023
He Wei-Wu: Major Shareholders
SC 13G
Monday, 4/10/2023
Huang James: Major Shareholders
Prospectus (9)
S-8 POS
Tuesday, 5/23/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 5/23/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 5/23/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 5/23/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 3/21/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 3/21/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 3/21/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 3/21/2023
Post-effective amendment to a S-8 registration statement
424B3
Tuesday, 2/14/2023
Prospectus filed pursuant to Rule 424(b)(3)